Detalhe da pesquisa
1.
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
Kidney Int;
2024 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38537676
2.
The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int;
2024 Jun 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38844295
3.
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
N Engl J Med;
384(17): 1601-1612, 2021 04 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33913638
4.
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
N Engl J Med;
384(17): 1589-1600, 2021 04 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33913637
5.
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
Circulation;
146(23): 1735-1745, 2022 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36335914
6.
Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int;
103(5): 842-858, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36731611
7.
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int;
104(4): 655-680, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37236424
8.
Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int;
104(6): 1076-1091, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37236423
9.
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int;
104(3): 441-454, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37290600
10.
Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney Int;
104(5): 888-903, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37245565
11.
Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group.
Kidney Int;
103(6): 1028-1037, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37023851
12.
Market Competition and Anemia Management in the United States Following Dialysis Payment Reform.
Med Care;
61(11): 787-795, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37721983
13.
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis.
Nephrol Dial Transplant;
38(10): 2358-2367, 2023 09 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37096396
14.
Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study.
Pediatr Nephrol;
38(1): 249-260, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35471462
15.
A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis.
J Am Soc Nephrol;
33(11): 2059-2070, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35981764
16.
Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States.
J Am Soc Nephrol;
33(6): 1063-1072, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35314456
17.
Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure.
Kidney Int;
102(4): 894-903, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35752324
18.
Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials.
Am J Nephrol;
53(10): 701-710, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36450264
19.
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Nephrol Dial Transplant;
37(11): 2241-2252, 2022 10 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35793567
20.
Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease.
Diabetes Obes Metab;
24(5): 928-937, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35118793